Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Zachary Bogue
AddedFeb 15, 2024
UpdatedJun 28, 2026
Zachary Bogue

Zachary Bogue

Co-Founder, Dcvc Bio

CrunchbaseThe Org

Zachary Bogue's Career

Dcvc Bio
Dcvc Bio

Palo Alto, CA, US

Co-Founder
Recursion Pharmaceuticals
Recursion Pharmaceuticals

Salt Lake City, UT, US

Board Member· Board
CH4 Global
CH4 Global

Henderson, NV, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Zachary Bogue's Career

Dcvc Bio
Dcvc Bio
Investment FirmInvestment Firm142018Palo Alto, CA, US
Co-Founder

Recent news

Sources: Naveen Rao’s new AI hardware startup targets $5B valuation with backing from a16zTechCrunch · 2025
TED leader’s $300M ‘valley of death’ fund might be just what later-stage climate tech needsTechCrunch · 2025
Rocket Lab backer Outset raises $25M to fund New Zealand’s deep tech moonshotsTechCrunch · 2025

Leadership at Dcvc Bio

Matthew OckoMatthew OckoCo-Founder
Kiersten SteadKiersten SteadCo-Founder
Anna FokinaAnna FokinaCo-Founder

Similar to Dcvc Bio

DcvcDcvcSan Francisco, CA, USest. 2011DcvcSan Francisco, CA, US · est. 2011

DCVC: A deep tech investment firm with 20+ years of backing industry-changing entrepreneurs.

Investment Firm91
DCMDCMMenlo Park, CA, USest. 1996DCMMenlo Park, CA, US · est. 1996

California-based financial services firm, DCM Ventures, partners with entrepreneurs to build impactful global tech companies.

Investment Firm275
Bioluminescence VenturesBioluminescence VenturesSan Francisco, CA, USest. 2022Bioluminescence VenturesSan Francisco, CA, US · est. 2022

US-based Bioluminescence, a biotech venture firm, invests in transformative science for next-gen medicines, focusing on breakthrough biology, drug discovery, and computational platforms.

Investment Firm7
DVCDVCSan Francisco, CA, USest. 2020DVCSan Francisco, CA, US · est. 2020

DVC: A global venture investor syndicate, funding companies from pre-seed to pre-IPO.

Investment Firm125
Recursion Pharmaceuticals
Recursion Pharmaceuticals
Public$665.4M5002013Salt Lake City, UT, US
Board Member· Board

Leadership at Recursion Pharmaceuticals

Zavain DarZavain DarBoard Member
Blake BorgesonBlake BorgesonBoard Member
Chris GibsonChris GibsonBoard Member
Dean LiDean LiBoard Member
Rob HershbergRob HershbergBoard Member
Terry-Ann BurrellTerry-Ann BurrellBoard Member

Similar to Recursion Pharmaceuticals

Lila SciencesLila SciencesCambridge, MA, USest. 2023Lila SciencesCambridge, MA, US · est. 2023

Lila builds scientific superintelligence software and autonomous laboratories for AI-driven research and experimentation.

Series A · $550M449
Genesis TherapeuticsGenesis TherapeuticsPalo Alto, CA, USBiotechnologyest. 2019Genesis TherapeuticsPalo Alto, CA, US · est. 2019

Genesis Therapeutics uses AI to discover novel small-molecule medicines for challenging disease targets.

Series B · $256.1M121
Isomorphic LabsIsomorphic LabsLondon, GBest. 2021Isomorphic LabsLondon, GB · est. 2021

Isomorphic Labs is an Alphabet-backed biotechnology company pioneering AI-driven drug discovery with a unified drug design engine.

Series B · $2.8B
CH4 Global
CH4 Global
Series B$45M472018Henderson, NV, US
Board Member· Board

Leadership at CH4 Global

Steve MellerSteve MellerCo-Founder
Nick GerritsenNick GerritsenCo-Founder
John HamerJohn HamerBoard Member
Guy RoyalGuy RoyalCo-Founder

Similar to CH4 Global

Blue Ocean BarnsBlue Ocean BarnsKailua-Kona, HI, USCattle Feedest. 2019Blue Ocean BarnsKailua-Kona, HI, US · est. 2019

Blue Ocean Barns: A public benefit corporation providing cattle feed to reduce livestock climate impact.

Public · $25.3M30
Macro OceansMacro OceansSan Francisco, CA, USChemicals, Materialsest. 2020Macro OceansSan Francisco, CA, US · est. 2020

San Francisco-based Macro Oceans innovates seaweed tech for restorative solutions.

Seed · $5M6
ArkeaBioArkeaBioReno, NV, USGHG Reduction, Vaccineest. 2022ArkeaBioReno, NV, US · est. 2022

Arkea Bio: Innovating tech solutions to reduce agricultural GHG emissions.

Seed · $12M15

Zachary Bogue's Co-Investors

Felix HaasFelix HaasCo-invested · SeedBrent HobermanBrent HobermanCo-invested · SeedLukasz GadowskiLukasz GadowskiCo-invested · SeedCarsten ThomaCarsten ThomaCo-invested · SeedIlkka PaananenIlkka PaananenCo-invested · SeedIlkka PaananenIlkka PaananenCo-invested · SeedDavid UlevitchDavid UlevitchCo-invested · ThirdLove SeedJason JohnsonJason JohnsonCo-invested · ThirdLove Seed

Zachary Bogue's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuHaeil YiHaeil YiCo-Founder · DunamuHyoung-nyon KimHyoung-nyon KimCo-Founder · Dunamu

People Similar to Zachary Bogue

Matt OckoMatt OckoBoard Member · Rocket LabDavid AhoDavid AhoBoard Member · ChronicledOliver HeimesOliver HeimesInvestor · PublicScott NolanScott NolanPartner · Founders FundWill SzczerbiakWill SzczerbiakBoard Member · EmergeZach WareZach WareFounder · VTF Capital